Pediatria Polska

Abstract

1/2018 vol. 93
Original paper

Long-term observation of ocular toxoplasmosis in immunocompetent children

Pediatr Pol 2018; 93 (1): 17–22
Online publish date: 2018/03/19
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease

Introduction

Toxoplasma gondii infection may result in retinochoroiditis and vision impairment.

Aim of the study

We conducted a long-term observation of symptoms and titres of serum anti-Toxoplasma IgG in children and adolescents. Thirty-four children (23 girls and 11 boys), aged one week to 18 years (mean 7.3 ±5.5 years) were observed for 2 to 17 years (mean 5.1 ±3.4 years). Diagnosis was based on detection of characteristic lesions in fundoscopy and positive serum anti-Toxoplasma IgG titres, and inflammation was confirmed by the leakage of dye in fluorescein angiography.

Results

In seven children the lesions were present at birth; they were bilateral and larger than 1 DD, in six of them they were accompanied by central nervous system abnormalities, and two children presented strabismus. Central localisation of toxoplasmosis, causing vision impairment, and inflammation recurrence, were found with similar frequency in these seven as in the other 27 children. Serum anti-T. gondii IgG ranged from 13 U/l to 1170 U/l, and titres were significantly higher in acute inflammation than in remission: 178 U/l vs. 90 U/l, p = 0.0016. Recurrences (one to three episodes) were noticed in 22/34 children: in all seven and in 15 out of 27 other children.

Conclusions

Ocular lesions in toxoplasmosis that initiated in foetal life were diffuse and led to progressive impairment of vision in childhood. Recurrence may be expected in more than half of all ocular toxoplasmosis cases despite antiparasitic treatment. Increase of serum anti-Toxoplasma IgG titre may indicate recurrence of retinochoroiditis.

Share
without publication fees
without publication fees